Advancing Progress in the Development and Implementation of Effective, High-Quality Cancer Screening: A Workshop

When: March 2, 2020 - March 3, 2020 (8:00 AM Eastern)
Where: Keck Center (100) • 500 Fifth St. NW, Washington, DC 20001

Topics Biomedical and Health Research, Diseases, Health Services, Coverage, and Access, Quality and Patient Safety
Activity: National Cancer Policy Forum
Board: Board on Health Care Services



Evidence-based screening approaches have contributed to improved patient outcomes, and research continues to develop and evaluate the potential of new strategies for early cancer detection. However, there are a number of challenges related to ensuring effective, high-quality screening. This workshop will examine current issues in cancer screening, featuring invited presentations and panel discussions on topics such as:

  • Key gaps in the evidence base for cancer screening, including assessing potential benefits and risks
  • Opportunities and challenges in developing, validating, and implementing new technologies for cancer screening
  • Strategies to help patients understand the benefits, risks, and costs of cancer screening and participate in shared decision-making with their care team
  • Opportunities to reduce disparities in cancer morbidity and mortality by facilitating patient access to high-quality screening and follow-up care

Planning Committee

  • Nicole Dowling (co-chair), Centers for Disease Control and Prevention
  • Stanton Gerson (co-chair), Case Western Reserve University
  • Garnet Anderson, Fred Hutchinson Cancer Research Center
  • Kenneth Anderson, Harvard Medical School
  • Edward Benz, Dana-Farber Cancer Institute
  • Otis Brawley, Johns Hopkins University
  • Sue Curry, University of Iowa College of Public Health
  • Nancy Davidson, Fred Hutchinson Cancer Research Center
  • Constantine Gatsonis, Brown University School of Public Health
  • Lori Hoffman Hōgg, Department of Veteran Affairs
  • Hedvig Hricak, Memorial Sloan Kettering Cancer Center
  • Alex Krist, Virginia Commonwealth University
  • Michelle Le Beau, University of Chicago Comprehensive Cancer Center
  • Lisa Richardson, Centers for Disease Control and Prevention
  • Sudhir Srivastava, National Cancer Institute
  • Robert Winn, Virginia Commonwealth University


  • Peter Albers, Heinrich-Heine-University Düsseldorf
  • Michael J. Barry, Harvard Medical School
  • Otis Brawley, Johns Hopkins University
  • Sara Brenner, Food and Drug Administration
  • Arul Chinnaiyan, Howard Hughes Medical Institute
  • Gwen Darien, National Patient Advocate Foundation
  • Laura Esserman, University of California San Francisco
  • Ruth Etzioni, Fred Hutchinson Cancer Research Center
  • Ann M. Geiger, National Cancer Institute
  • Hedvig Hricak, Memorial Sloan Cancer Center
  • Masahito Jimbo, University of Michigan
  • Barnett Kramer, National Cancer Institute
  • Alex Krist, Virginia Commonwealth University
  • J. Leonard Lichtenfeld, American Cancer Society
  • Jeanne Mandelblatt, Georgetown University
  • Usha Menon, University College of London
  • Jacqueline W. Miller, Centers for Disease Control and Prevention
  • Nickolas Papadopoulos, The Johns Hopkins Institutions
  • Rebecca D. Pentz, Emory University School of Medicine
  • Michael Pignone, University of Texas Austin
  • David Ransohoff, University of North Carolina, Chapel Hill
  • Wendy Rubinstein, Food and Drug Administration 
  • Carolyn Rutter, RAND Corporation
  • Kathleen M. Schmeler, The University of Texas MD Anderson Cancer Center
  • Sudhir Srivastava, National Cancer Institute




Upcoming Meetings for this Activity

Previous Meetings for this Activity

Also of Interest